| Literature DB >> 31362402 |
Soraia I Falcão1, Ricardo C Calhelha2, Soumaya Touzani3, Badiaâ Lyoussi3, Isabel C F R Ferreira2, Miguel Vilas-Boas4.
Abstract
Propolis is a resin manufactured by bees through the mixture of plant exudates and waxes with secreted substances from their metabolism, resulting in a complex mixture of natural substances of which quality depends on the phytogeographic and climatic conditions around the hive. The present study investigated the contribution of phenolic compounds to the cytotoxic and anti-inflammatory activities of propolis. The phenolic composition was evaluated by liquid chromatography with diode-array detection coupled to electrospray ionization tandem mass spectrometry (LC/DAD/ESI-MSn) analysis after phenolic extraction. The cytotoxicity of the extracts was checked using human tumor cell lines (MCF7- breast adenocarcinoma, NCI-H460- non-small cell lung carcinoma, HeLa- cervical carcinoma, HepG2- hepatocellular carcinoma, and MM127- malignant melanoma), as well as non-tumor cells (a porcine liver primary culture-PLP2). The anti-inflammatory activity was assessed using the murine macrophage (RAW 264.7) cell line. The results showed a composition rich in phenolic acids, such as caffeic and p-coumaric acid, as well as flavonoids, such as pinocembrin, pinobanksin, and pinobanksin-3-O-butyrate. Samples MP2 from Sefrou and MP3 from Moulay Yaâcoub presented a high concentration in phenolic compounds, while MP1 and MP4 from Boulemane and Immouzzer Mermoucha, respectively, showed similar composition with low bioactivity. The higher concentration of phenolic compound derivatives, which seems to be the most cytotoxic phenolic class, can explain the pronounced antitumor and anti-inflammatory activity observed for sample MP2.Entities:
Keywords: anti-inflammatory; cytotoxicity; phenolic compounds; propolis; tumor cells
Mesh:
Substances:
Year: 2019 PMID: 31362402 PMCID: PMC6723880 DOI: 10.3390/biom9080315
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Phenolic compounds in Moroccan propolis identified and quantified by LC/DAD/ESI-MSn (each value is the mean ± standard deviation, n = 2).
| Peak | Proposed Compound | RT (min) | λmax | [M − H]− | MSn | MP1 | MP2 | MP3 | MP4 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Caffeic acid a,b | 10.9 | 322 | 179 | MS2 [179]: 135 | 0.31 ± 0.00 | 0.50 ± 0.00 | 0.31 ± 0.00 | 0.30 ± 0.00 |
| 2 | 15.8 | 310 | 163 | MS2 [163]: 119 | 0.22 ± 0.00 | 0.21 ± 0.00 | 0.16 ± 0.00 | 0.50 ± 0.00 | |
| 3 | Pinobanksin-5-methyl-ether b,c | 36.9 | 286 | 285 | MS2 [285]: 267 (100), 253 (13), 239 (27) | 0.77 ± 0.01 | |||
| 4 | Sterubin b,d | 47.3 | 284 | 301 | MS2 [301]: 286 (100), 165 (8); MS3 [286]: 258 (37), 195 (17), 165 (100) | 0.83 ± 0.01 | |||
| 5 | Pinobanksin b,c | 47.3 | 292 | 271 | MS2 [271]: 253 (100), 225 (26), 151 (10) | 0.83 ± 0.00 | 2.04 ± 0.00 | 1.14 ± 0.03 | 0.83 ± 0.01 |
| 6 | Dihydrokaempferide b,e | 50.4 | 291 | 301 | MS2 [301]: 283 (100), 151 (22); MS3 [283]: 268 (100), 255 (40), 227 (41) | 0.86 ± 0.01 | |||
| 7 | Apigenin a,b | 54.9 | 268, 337 | 269 | MS2 [269]: 225 (100), 151 (29) | 0.27 ± 0.00 | |||
| 8 | Kaempferol-methyl ether b,c | 57.7 | 265, 352 | 299 | MS2 [299]: 284 | 0.15 ± 0.01 | 0.26 ± 0.00 | ||
| 9 | 3-prenyl- | 63.6 | 315 | 231 | MS2 [231]: 187; MS3 [187]: 132 | 0.71 ± 0.00 | |||
| 10 | Caffeic acid isoprenyl ester a,b | 65.2 | 325 | 247 | MS2 [247]: 179 (100), 135 (13) | 0.34 ± 0.00 | 1.73 ± 0.01 | 1.40 ± 0.00 | |
| 11 | Caffeic acid isoprenyl ester b,c | 66.3 | 325 | 247 | MS2 [247]: 179 (100), 135 (13) | 0.35 ± 0.01 | 3.00 ± 0.01 | 2.59 ± 0.00 | |
| 12 | Capillartimisin A b,e | 66.4 | 309 | 315 | MS2 [315]: 285 (60), 271 (100), 241 (67); MS3 [271]: 253 (41), 241 (100) | 0.21 ± 0.00 | |||
| 13 | Caffeic acid benzyl ester b,c | 66.7 | 325 | 269 | MS2 [269]: 178 (100), 161 (12), 134 (32) | 0.43 ± 0.01 | 1.18 ± 0.03 | 0.90 ± 0.02 | |
| 14 | Pinocembrin a,b | 67.6 | 289 | 255 | MS2 [255]: 213 (100), 211 (32), 151 (48) | 1.17 ± 0.04 | 3.91 ± 0.15 | 2.80 ± 0.03 | 1.81 ± 0.00 |
| 15 | Isosakuranetin b,f,g | 68.1 | 292 | 285 | MS2 [285]: 270 (100), 243 (25), 164 (17), 151 (4) MS3 [270]: 242 (41), 165 (100), 164 (70) | 0.92 ± 0.00 | |||
| 16 | Benzoyl hydroxyphenyl acetic acid b,f | 68.4 | 280 | 257 | MS2 [257]: 213; MS3 [213]: 169 (100), 122 (49) | 0.61 ± 0.02 | |||
| 17 | Chrysin a,b | 69.6 | 268, 313 | 253 | MS2 [253]: 225 (17), 209 (100), 151 (5) | 0.25 ± 0.08 | 1.99 ± 0.14 | 2.88 ± 0.01 | 0.27 ± 0.03 |
| 18 | Pinobanksin-3- | 69.6 | 292 | 313 | MS2 [313]: 271 (20), 253 (100) | 1.22 ± 0.02 | 6.82 ± 0.06 | 1.01 ± 0.00 | 0.96 ± 0.02 |
| 19 | Caffeic acid phenylethyl ester a,b | 69.9 | 325 | 283 | MS2 [283]: 179 (100), 135 (22) | 0.37 ± 0.02 | 1.24 ± 0.03 | 0.57 ± 0.00 | |
| 20 | Galangin a,b | 70.3 | 265, 300sh, 358 | 269 | MS2 [269]: 269 (100), 241 (61), 227 (20), 197 (22), 151 (20) | 1.04 ± 0.02 | 0.35 ± 0.00 | ||
| 21 | Caffeic acid pentyl ester b | 71.1 | 325 | 249 | MS2 [249]: 179 (100), 161 (47), 135 (32) | 0.62 ± 0.00 | |||
| 22 | 6-Methoxychrysin b,c | 72.3 | 265, 300sh, 350sh | 283 | MS2 [283]: 269 | 0.88 ± 0.05 | 0.48 ± 0.04 | ||
| 23 | Pinobanksin-3- | 75.2 | 289 | 327 | MS2 [327]: 271 (9), 253 (100) | 1.08 ± 0.01 | |||
| 24 | Unknown | 79.5 | 239 | 377 | MS2 [377]: 359 (100), 331 (84), 313 (8) | 2.76 ± 0.04 | 4.31 ± 0.03 | ||
| 25 | Pinobanksin-3- | 79.9 | 292 | 341 | MS2 [341]: 271 (2), 253 (100) | 2.66 ± 0.01 | |||
| 26 | Pinobanksin-3- | 84.1 | 292 | 355 | MS2 [355]: 271 (3), 253 (100) | 0.80 ± 0.00 |
a Confirmed with standard; b Confirmed with MSn fragmentation; c Confirmed with references: [12]; d [21]; e [22]; f [23]; g [24].
Figure 1Principal phenolic classes presented in the composition of propolis from different Morocco origins.
Figure 2Cytotoxic activity of propolis samples on cell lines expressed in GI50 values (µg/mL) (mean ± SD, n = 2). GI50 values correspond to the extract concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2.
Spearman’s correlations between the propolis phenolic composition (mg/g of extract) and cytotoxicity and anti-inflammatory activity GI50/IC50 values (μg/mL).
| NCI-H460 | HeLa | HepG2 | MCF-7 | MM127 | PLP2 | RAW264.7 | |
|---|---|---|---|---|---|---|---|
| Phenolic acids | 0.786 a | 0.381 | 0.786 a | 0.452 | 0.357 | 0.881 a | 0.357 |
| Phenolic acid derivatives | −0.810 a | −0.976 b | −0.762 a | −0.833 a | −0.952 b | −0.500 | −0.905 b |
| Dihydroflavonols | 0.024 | −0.381 | 0.024 | −0.310 | −0.357 | 0.429 | −0.381 |
| Dihydroflavonols derivatives | −0.405 | −0.810 a | −0.357 | −0.619 | −0.738 a | −0.310 | −0.857 b |
| Flavonols | −0.710 a | −0.913 b | −0.710 a | −0.862 b | −0.888 b | −0.317 | −0.875 b |
| Flavones | −0.881 b | −0.619 | −0.881 b | −0.690 | −0.690 | −0.548 | −0.500 |
| Flavanones | −0.619 | −0.786 a | −0.571 | −0.643 | −0.762 a | −0.167 | −0.667 |
| Total phenolics | −0.595 | −0.762 a | −0.548 | −0.667 | −0.786 a | −0.143 | −0.643 |
Spearman’s correlation significance levels: a Correlation is significant at p < 0.05; b Correlation is significant at p < 0.01.
Figure 3Anti-inflammatory activity of propolis samples expressed in IC50 values (µg/mL) of NO production inhibition (mean ± SD, n = 2). IC50 values correspond to the extract concentration achieving 50% of the inhibition of the NO production.